title: Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis.
authors.forename: Takao
authors.initials: T
authors.lastname: Nagashima
authors.forename: Hikaru
authors.initials: H
authors.lastname: Okubo-Fornbacher
authors.forename: Yoko
authors.initials: Y
authors.lastname: Aoki
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Kamata
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Kimura
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kamimura
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nara
authors.forename: Masahiro
authors.initials: M
authors.lastname: Iwamoto
authors.forename: Taku
authors.initials: T
authors.lastname: Yoshio
authors.forename: Hitoaki
authors.initials: H
authors.lastname: Okazaki
authors.forename: Seiji
authors.initials: S
authors.lastname: Minota
mesh_terms: D052242:Adiponectin / Q000097:blood*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000208:ethnology; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D000069285:Infliximab; D007564:Japan; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012044:Regression Analysis; D012720:Severity of Illness Index; D012727:Sex Characteristics; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D052242:Adiponectin; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept